LEDERLE’s ZEBETA ADDED TO MEDI-CAL LIST OF COVERED BETA BLOCKERS FOLLOWING CATEGORY REVIEW; MERCK ANTILIPIDEMIC ZOCOR ON PRIOR APPROVAL AS OF MARCH 1